Introduction
Cells that are subjected to double-stranded breaks (DSBs) in their DNA activate cell cycle checkpoints and alter specific gene transcription patterns to allow the DNA repair machinery to correct the damage and preserve the integrity of the genome (Valerie and Povirk, 2003) . The predominant DSBs repair pathway in higher eukaryotic cells is the non-homologous DNA endjoining pathway (NHEJ) (Lees-Miller and Meek, 2003; Lieber et al., 2003) . Defects in DNA-break repair are a major cause of genomic instability that leads to the development of cancer.
A key NHEJ factor is the DNA-dependent protein kinase (DNA-PK). DNA-PK is comprised of a large catalytic subunit, DNA-PKcs, and the Ku antigen heterodimer (Ku70/Ku80) (Smith and Jackson, 1999) . DNA-PK is essential in maintaining genomic integrity, as mice lacking either DNA-PKcs or Ku suffer from profound radiosensitivity, immunodeficiency and age prematurely (Ferguson and Alt, 2001; Lieber et al., 2003) . At the cellular level, DNA-PK deficiency results in defective repair of DSBs and defects in telomere maintenance that lead to telomeric fusions and translocations (Lieber et al., 2003; Bailey and Goodwin, 2004; Collis et al., 2005) .
DNA-PK exhibits Ser/Thr kinase activity and displays a strong preference for S/T-Q motifs, although S/ T's flanked by residues other than Q are also recognized on occasion (Chan et al., 1999; Kim et al., 1999) . Suggested substrates for DNA-PK include several factors of the NHEJ pathway (Meek et al., 2004; Collis et al., 2005) . DNA-PK is also known to autophosphorylate (Chan et al., 2002; Douglas et al., 2002; Soubeyrand et al., 2003) . A role for DNA-PK in signaling to apoptosis machinery has been documented (Bharti et al., 1998; Wang et al., 2000; Woo et al., 2002; Sawada et al., 2003) . However, the potential for DNA-PK to act as a signaling molecule in regulating other cellular responses to DSBs remains to be elucidated.
Octamer transcription factor-1 (Oct-1) has recently emerged as an important contributor to cell survival in response to various types of DNA damage (Tantin et al., 2005) . Somewhat paradoxically, we have determined that Oct-1 protein levels increase subsequent to ionizing radiation (IR) exposure, whereas at the same time H2B and U2 expression is down-regulated (Zhao et al., 2000a; Jin et al., 2001; Schild-Poulter et al., 2003) .
Oct-1 is a ubiquitous transcription factor of the POU (Pit/Oct-1/2-Unc) subfamily of homeodomain proteins (Herr and Cleary, 1995; Ryan and Rosenfeld, 1997) and is a key regulator of housekeeping genes such as H2B and U2 (Sive and Roeder, 1986; Fletcher et al., 1987) . Oct-1 also participates in the transcriptional regulation of many signal-regulated and tissuespecific genes and in the control of viral replication (Herr and Cleary, 1995; Ryan and Rosenfeld, 1997; de Jong and van der Vliet, 1999; Phillips and Luisi, 2000) . Oct-1 is essential for embryonic development as Oct-1-deficient embryos die during gestation (Wang et al., 2004) .
Recently, we determined that the stabilization of Oct-1 in response to IR correlated with an overall molar increase in Oct-1 phosphorylation and physical interaction with Ku . In vitro experiments showed that the association of Oct-1 with Ku facilitated the phosphorylation of Oct-1 by DNA-PK (Schild-Poulter et al., 2001 .
Here, we have identified 15 specific phosphorylation sites for DNA-PK on Oct-1, 13 of which occur within the N-terminal glutamine-rich Oct-1 transcriptional regulatory domain. Substitution of these 13 residues with alanine incrementally prevented Oct-1 stabilization in response to IR and abrogated the IR-induced Oct-1 phosphorylation previously shown to be dependent on DNA-PK. Notably, the alanine-substituted Oct-1 failed to rescue the radiation sensitivity of Oct-1 À/À mouse embryonic fibroblasts (MEFs) seen upon re-expression of wild-type (WT) Oct-1. These results provide the first evidence of a role for DNA-PK as a signaling molecule in promoting cell survival in response to DSBs through modulation of the activity of the transcription factor Oct-1.
Results
Oct-1 binding to the H2B promoter is unaffected by DNA damage Oct-1 is readily visualized on the H2B promoter in proliferating cells (Zhao et al., 2000b) . In response to IR treatment, H2B transcription decreases (MeighanMantha et al., 1999; Schild-Poulter et al., 2003; Su et al., 2004) , suggesting that phosphorylation of Oct-1 in response to IR could influence the recruitment of Oct-1 to the histone H2B promoter. To assess how IR exposure affected Oct-1-dependent transcription in vivo, we performed a chromatin immunoprecipitation (ChIP) analysis of the H2B promoter ( Figure 1a ). The decrease in histone H2B transcription upon IR exposure ( Figure 1b ) correlated with a rapid decrease in the presence of RNA polymerase II and TATA box-binding protein ( Figure 1a ). ChIP with a histone H4 pan-acetyl lysine antibody revealed a parallel decline in the level of histone H4 acetylation over the H2B promoter. This was not a general effect of DNA damage as total acetylated histone H4 levels remain unchanged (Figure 1c) .
By contrast, the down-regulation of H2B transcription in response to IR was accomplished without affecting the promoter occupancy of Oct-1 (Figure 1a) . Thus, the IR-dependent modification of Oct-1 that leads to its stabilization did not appear to affect its targeting to chromatin. This result was consistent with previous observations that Oct-1 DNA-binding to an octamer motif was unaffected in extracts prepared from cells subjected to IR treatment (Meighan-Mantha et al., 1999; Zhao et al., 2000a) . This suggested that the salient phosphorylation sites for the IR response were outside of the POU DNA-binding domain of Oct-1 that interacts with Ku.
DNA-PK phosphorylates Oct-1 at multiple sites in vitro The Oct-1 POU domain is flanked by a N-terminal region exhibiting a strong Q-rich character and a C-terminus containing a S/T-rich region (Figure 2a) . To investigate the hypothesis that the DNA-PKdependent changes in Oct-1 subsequent to treatment with DNA-damaging agents resulted from direct phosphorylation, we initiated a characterization of the Oct-1 residues phosphorylated by purified preparations of DNA-PK in vitro.
Initial work had indicated that one region of Oct-1 that could be efficiently phosphorylated by DNA-PK (d) Oct-1 N-terminal region (Oct-1 aa 1-268) was expressed as a GST-fusion protein with ( þ ) or without (À) the HOXC4 homeodomain (HOXC4 HD). The purified proteins were phosphorylated in vitro by DNA-PK and run on a SDS-PAGE. The protein levels were visualized by coomassie staining and the phosphorylation by autoradiography. The arrows indicate the GST-Oct-1 peptides. (e) Schematic of the GST-HOXC4 constructs generated for the DNA-PK phosphorylation analysis and representative SDS-PAGE analysis of the purified 32 P-labeled peptides after phosphorylation by DNA-PK. The coomassie staining and autoradiogram of the same gel are shown. (f) Identification of the DNA-PK phosphorylation sites in Oct-1 A, B and C sub-fragments. The partial sequence of each of the A, B and C fragments containing the DNA-PK phosphorylation sites is indicated. The residues phosphorylated are underlined and their position in the Oct-1 sequence is indicated below. (g-i) Effect of alanine substitution of the residues identified in Oct-1 A, B and C fragments on DNA-PK phosphorylation. Amino acids identified in (f) were mutated to alanine in each fragment. (g) WT and mutant peptides GST-HOXC4 Oct-1A, (h) B and (i) C were phosphorylated in vitro by DNA-PK. Coomassie staining and an autoradiograph of the same gel are shown. (j) Alanine substitutions of all residues in the A, B and C clusters prevent phosphorylation of Oct-1 N-terminal domain. The GST-HOXC4-Oct-1 N-terminal construct (Oct-1 aa 1-268) was expressed as WT or mutant protein-bearing alanine substitutions at the 13 residues identified in the A, B and C clusters. DNA-PK phosphorylation of the WT and mutant (ABC) proteins is shown with the Coomassie staining and the 32 P incorporation of the same gel.
Modulation of cell survival through Oct-1 phosphorylation C Schild-Poulter et al in vitro was a peptide encoding aa 268 to aa 446, which encompassed the Oct-1 POU domain (Schild-Poulter et al., 2001 . Tryptic analysis and sequencing revealed T276/S278, present at the edge of the POU domain, as the targets sites for DNA-PK in this region (Supplementary Figure 1) . Analysis of full-length Oct-1 also revealed the presence of a prominent high-mobility peptide phosphorylated by DNA-PK (Figure 2b, arrow) . Trypsin digestion of Oct-1 generates only one large peptide in the N-terminal domain (aa 74-254, Figure 2c ). This correlated well with our previous results showing that a peptide comprising the N-terminal part of Oct-1 was phosphorylated by DNA-PK, whereas the C-terminus portion of Oct-1 was not . This peptide was previously shown to encompass a glutamine-rich transcriptional regulatory domain (Seipel et al., 1992) .
To analyze the DNA-PK phosphorylation sites within this region of Oct-1, we produced three peptides spanning the large tryptic peptide (A, B, C; Figure 2c ). As shown previously (Schild-Poulter et al., 2001) , the phosphorylation of Oct-1 by DNA-PK was dependent on the interaction of Ku with the homeodomain. Thus, addition of a neutral HOXC4 homeodomain to the N-terminus of Oct-1 replaced the Oct-1 homeodomain in promoting strong phosphorylation of the peptide (Figure 2d) . Addition of the same HOXC4 homeodomain was therefore used to facilitate the phosphorylation of the A, B and C peptides to allow phosphopeptide mapping (Figure 2e ).
DNA-PK phosphorylated each of the three fragments, A, B and C, with the molar incorporation of phosphate being significantly less for peptide C (Figure 2e ). Edman degradation analysis of DNA-PKphosphorylated Oct-1 A fragment showed 32 P release at six positions (Figure 2f ), which, upon mutation to alanine, reduced Oct-1 A peptide phosphorylation by DNA-PK beyond our limit of detection (Figure 2g) .
Identification of the DNA-PK phosphorylation sites in peptides B and C required additional manipulation beyond monitoring of 32 P release. Through a combination of site-directed mutagenesis and chymotryptic digestion of the peptides, we defined five DNA-PK phosphorylation sites in peptide B (Figure 2f ). Through a similar strategy, T226 and S232 were characterized as the DNA-PK phosphorylation sites in peptide C, which was consistent with the lower level of total phosphate incorporation into the peptide. S/T-A substitution of the five residues in peptide B completely eliminated phosphorylation by DNA-PK (Figure 2h ). Similarly T226A/ S232A substitution prevented phosphorylation of peptide C (Figure 2i ).
To confirm these findings, a glutathione S-transferase (GST)-Oct-1 N-terminal fusion protein in which the 13 S/T's identified as DNA-PK targets within peptides A, B and C were substituted with alanine was generated. Phosphorylation of this mutant peptide showed very little residual phosphorylation by DNA-PK (less than 10%, Figure 2j ), indicating that we had identified the majority of DNA-PK sites in the Oct-1 N-terminal region. Significantly, all 13 residues phosphorylated by DNA-PK are conserved between human and murine Oct-1.
Substitution of DNA-PK phosphorylation sites in the Oct-1 N-terminus prevents upregulation and phosphorylation in response to IR To investigate the importance of the residues targeted by DNA-PK in vitro for the stabilization of Oct-1 in mammalian cells in response to IR treatment, we expressed HA-tagged Oct-1-bearing S/T-A substitutions across the N-terminal A, B and C regions (mtABC) in Oct-1-deficient 3T3-immortalized MEFs (Wang et al., 2004) . As described previously , WT HA-Oct-1 expressed by transient transfection in the MEFs was stabilized about two fold following IR exposure (Figure 3a) . By contrast, the levels of the newly constructed mtABC mutant were unaffected by IR 1-3) or Oct-1 mtABC (lanes 4-6) were incubated with a Ku70 antibody (lanes 2 and 5) or with a non-specific Gal4 DBD antibody (lanes 3 and 6). Immunoprecipitates were run on SDS-PAGE and hybridized with an HA antibody to detect transfected Oct-1 (top) and a Ku70 antibody (bottom) and compared to 5% input extract (I, lanes 1 and 4) .
Modulation of cell survival through Oct-1 phosphorylation C Schild-Poulter et al treatment. Thus, the S/T residues in the N-terminus of Oct-1 recognized by DNA-PK made an essential contribution to the stabilization of Oct-1 in response to IR. However, T276/S278 adjacent to the POU domain alone did not appear to be sufficient to allow Oct-1 stabilization.
To assess whether the stabilization effect might be localized to a more limited subset of S/T residues in Oct-1, we assessed the IR response of Oct-1 mutants with S/T-A substitutions in each of the A, B and C regions individually (mtA, mtB, mtC; Figure 3b ). All of these more focused Oct-1 mutants exhibited a partial stabilization response to IR. By contrast, Oct-1 with substitutions in cluster D (Oct-1 D) was up-regulated to levels similar to the WT protein. This suggested that Oct-1 stabilization following IR treatment was mediated by the cumulative effects of residues phosphorylated in Oct-1 regions A, B and C. Importantly, the interaction between Oct-1 and Ku (Schild-Poulter et al., 2001 was not affected by the amino-acid substitutions in Oct-1 mtABC (Figure 3c ).
To determine whether the substitutions in mtABC affected the phosphorylation of Oct-1 in response to DSBs, we compared 32 P-incorporation in WT Oct-1 and mtABC following DNA damage (Figure 4 ). In these experiments, the radiomimetic compound Zeocin, was substituted for IR. Previously, we have shown that the stabilization and DNA-PK-dependent phosphorylation of Oct-1 is the same following Zeocin treatment as subsequent to IR . WT Oct-1 phosphorylation was increased 2.4-fold in Zeocintreated cells compared to control cells. The Oct-1 mtABC, however, showed no change in P i incorporation following Zeocin treatment, demonstrating that the S/T substitutions in the N-terminus of Oct-1 abrogated the DNA-damage-induced phosphorylation of Oct-1 . Therefore, we conclude that the DNA-PK-dependent phosphorylation of Oct-1 in response to double-stranded DNA breaks was mediated predominantly by phosphorylation at 13 sites within the N-terminal Oct-1 Q-rich activation domain.
Oct-1 mtABC fails to rescue IR sensitivity of Oct-1 À/À MEFs Oct-1-deficient cells are hypersensitive to various DNAdamaging agents, including IR (Tantin et al., 2005) . To investigate the role of Oct-1 phosphorylation within the Q-rich domain DNA-PK cluster identified in this study in promoting resistance to IR, we compared the ability of WT Oct-1 and Oct-1 mtABC to rescue the survival of Oct-1-deficient MEFs following exposure to IR. Cell survival in these experiments was assessed through a proliferation assay (Eble et al., 1994; Loong et al., 2004) , as neither the Oct-1 À/À cells nor their matched WT counterpart ( þ / þ ) are able to form colonies (data not shown). As shown previously (Tantin et al., 2005) , Oct-1 À/À MEFs (KO) were hypersensitive to IR compared to the þ / þ MEFs ( Figure 5) . Indeed, the increase in sensitivity of Oct-1 À/À cells was comparable to that observed for Ku70 À/À MEFs in this assay (Supplementary Figure 2) .
Re-expression of WT Oct-1 through viral expression completely restored the resistance of Oct-1 À/À MEFs to IR ( Figure 5 ). By contrast, cells expressing the Oct-1 mtABC remained hypersensitive to IR, with a survival curve closely matching the mock-infected KO MEFs, even though mtABC was expressed to the same levels as WT Oct-1 (Figure 5, inset) . As for transiently transfected MEFs, IR treatment stabilized WT Oct-1 protein levels but was without effect on the mtABC protein (data not shown). We conclude that the S/T residues in the N-terminal domain phosphorylated by DNA-PK constitute an important regulatory target on Oct-1 that is essential for the contribution of Oct-1 to cell survival following exposure to IR.
Discussion
Previously, we have observed that Oct-1 undergoes DNA-PK-dependent phosphorylation in response to DSBs and that Oct-1 makes an important contribution to the cells ability to survive this damage Tantin et al., 2005) . Here, we provide compelling evidence that the contribution of Oct-1 to cell survival in response to DSBs is dependent on DNA-PK phosphorylation that occurs over 13 sites in Oct-1's N-terminal Q-rich transcriptional regulatory domain.
Substitution of the 13 S/T residues in the Q-rich transcriptional regulatory domain with alanine completely suppressed DNA damage-induced Oct-1 phosphorylation and Oct-1 stabilization. It also abrogated the contribution of Oct-1 towards cell survival subsequent to IR treatment. The Q-rich domain of Oct-1 contains 32 S/T residues and a number of additional S/T's flank the domain on either side. Thus, the extensive DNA-PK phosphorylation within this region was selective and consistent with a specific response. Further, substitution of two other DNA-PK phosphorylation sites flanking the POU domain (T276 and S278) had no discernible effect on the response of Oct-1 to DNA damage. Figure 4 Oct-1 phosphorylation in response to IR is inhibited by alanine substitution at the three A, B and C clusters. Oct-1-deficient 3T3 MEFs infected with recombinant retrovirus expressing WT Oct-1 or Oct-1 with alanine substitutions at DNA-PK phosphorylation clusters A, B and C (mtABC) were incubated in the presence of 32 P-P i in the presence ( þ ) or absence (À) of Zeocin. Equal amount of immunoprecipitated Oct-1 were run on SDS-PAGE and transferred to polyvinylidene fluoride membrane.
32 P incorporation was analysed by phosphorimager, and Oct-1 protein levels assessed by Western blot analysis with an HA antibody.
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Multi-site phosphorylation has been documented for several factors, including Sic1 (Nash et al., 2001) , NFAT (Okamura et al., 2000) , Stat6 (Maiti et al., 2005) and Ets-1 (Pufall et al., 2005) . It has been suggested to overcome a threshold needed to establish a biological response (Nash et al., 2001; Gunawardena, 2005; Pufall et al., 2005) . That this also may apply to Oct-1 is reflected by the additive effects of the sites within the A, B and C subregions. More refined mutagenesis in Oct-1 combined with the use of antiphosphoserine/threonine antibodies will be necessary to determine the extent to which cooperativity in phosphorylation is required for the DNA-damage response of Oct-1.
Oct-1 is stabilized and its activity is modified by DNA-PK in response to DSBs. Yet, similar effects on Oct-1 have also been implicated in the cellular response to other types of DNA damage, such as ultraviolet, cisplatin and methylmethane sulfonate, which do not lead to the activation of DNA-PK (Zhao et al., 2000a) . Recent work has indicated that Oct-1 is involved in the transcriptional regulation of ultraviolet-induced genes (Jin et al., 2001; Takahashi et al., 2001; Luo et al., 2003) and we have shown that Oct-1 deficiency results in increased sensitivity to several DNA-damaging agents (Tantin et al., 2005) . Thus, it will be interesting to determine the extent to which the 13 S/T residues identified in this study play a role in the response of Oct-1 to other DNA-damaging agents.
The most plausible consequence of phosphorylation within the Oct-1 Q-rich is to modulate Oct-1-dependent transcription. Indeed, we have identified a number of genes whose regulation is altered in Oct-1-deficient cells in response to IR, including genes involved in oxidative and metabolic stress (Tantin et al., 2005) . Several of these genes contain octamer motifs in their regulatory regions. In addition, a recent study has suggested that Oct-1 may be involved in the survival of lymphoma cells through the regulation of bcl-2 expression (Heckman et al., 2005) .
Phosphorylation within transcriptional regulatory domains is well known to regulate the assembly of transcription factor complexes (Whitmarsh and Davis, 2000; Holmberg et al., 2002) . Q-rich transcriptional regulatory domains have been described for several nuclear factors including AP-2, GAGA factor, the Sp-family of transcription factors, CREB/CREM and transcriptional coactivators such as p300 and the SRC family (Kraus et al., 1999; Wilkins and Lis, 1999; Leo and Chen, 2000; Servillo et al., 2002; Li et al., 2004) . These domains function to mediate the assembly of multiprotein transcriptional regulatory complexes. The presence of S/TQ motifs within these domains suggests the potential for these activities to be also regulated by DNA-PK-related kinases.
Little is known of the mechanism of action of the Q-rich domain of Oct-1. To date, only one factor has been reported to interact with Oct-1 through this region (Sp1; Strom et al., 1996) . Thus, determining the molecular consequences of phosphorylation within the Oct-1 Q-rich domain will depend on a more detailed characterization of the transcriptional regulatory activity and protein-protein interaction potential of this region of Oct-1.
Although our data would seem most consistent with Oct-1 phosphorylation modulating its transcriptional regulation potential, it remains feasible that phosphorylation of the Oct-1 Q-rich domain could influence the participation of Oct-1 in other processes. For example, there have been suggestions of the involvement of Oct-1 in DNA replication (de Jong and van der Vliet, 1999) and DNA damage is known to affect DNA replication timing. Additionally, as DNA-PK relies on association ) MEFs were cultured as described (Sawada et al., 2003) . 3T3-immortalized MEFs derived from WT and Oct-1-deficient mice have been described previously (Wang et al., 2004) . For irradiation experiments, cells were plated the night before irradiation at 50-70% confluency. Irradiations were performed using a Pantak irradiator at a dose rate of 1.68 Gy/min.
Transfections assays 3T3 MEFs and HEK 293T cells were transfected with FuGENEt 6 (Roche Diagnostics, Laval, QC, Canada) according to the manufacturer's instructions. For Oct-1 protein expression studies, 100-mm plates were transfected with 0.5 mg of pCGNOct-1 constructs. For retroviral infections, pMSCV-retrovirus generated in Phoenix Ampho cells (ATCC, SD 3443, Manassas, VA, USA) was used to infect Oct-1 KO MEFs. Twenty-four hours later, cells were selected with 1 mg/ml puromycin.
Western Blot analyses
Whole-cell extracts for the analysis of Oct-1 mutants were prepared as described (Schild-Poulter et al., 2001) , in wholecell extract buffer supplemented with 1mM sodium vanadate and 20 mM NaF. For histone H4 analysis, cells were lysed in 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM ethylenediaminetetraacetic acid, 0.5% Triton X-100, 0.5 mM dithiothreitol for 10 min on ice. The lysate was centrifuged and the pellet resuspended in dye-free 1 Â sodium dodecyl sulfate-polyacrylamide (SDS-PAGE) gel electrophoresis loading buffer. Fifteen micrograms were loaded on SDS-PAGE and processed for Western blot analysis.
Co-immunoprecipitation experiments were carried out essentially as described (Schild-Poulter et al., 2001) . Gels were transferred on polyvinylidene fluoride membranes (Bio-Rad, Hercules, CA, USA) and hybridized with the indicated antibodies (see Supplementary Methods).
ChIP assays
About 5 Â 10 6 MCF-7 cells were harvested for ChIP assays and processed according to previously published procedures (Wiper-Bergeron et al., 2003) as described in Supplementary Methods.
Survival assay
As 3T3 MEFs do not form single colonies (data not shown), clonogenic assays cannot be implemented with these cell lines, so the CellTiter 96 Aqueous one assay (Promega, Madison, WI, USA) was used to determine the viable cells, according to the manufacturer's protocol and conditions described previously for this assay (Eble et al., 1994; Loong et al., 2004) . The range of cell number to be plated was initially determined by analysis of increasing cell number to determine the range of linearity between cell number and optical density. For survival assays, cells were plated one day before irradiation in 96-well titer plates at various densities in duplicate or triplicate. Following IR treatment, cells were returned to the incubator for 4 days before being assayed with CellTiter 96 for viability. Optical densities were read after 1, 2 and 4 h incubations. Only optical density values in the pre-determined linear range were taken in to consideration for calculations of survival. The statistical significance was evaluated using a one-way analysis of variance with a Student-Newman-Keuls post-test using GraphPad InStat program.
Phosphorylation of Oct-1 in vivo Retrovirally infected Oct-1 KO MEFs expressing WT Oct-1 or mtABC were incubated with phosphate-free medium for 1 h, followed by the addition of 100 mg/ml Zeocin and 0.25 mCi/ml 32 P-P i . In these experiments, Zeocin was substituted for IR treatment owing to the relatively large amount of 32 P used in the assay. After 30 min incubation, whole-cell extracts were prepared, followed by immunoprecipitation and the analysis was carried out as described .
Phosphorylation of Oct-1 by DNA-PK in vitro GST fusion proteins were expressed according to standard protocols (Amersham Biosciences Corp., Piscataway, NJ, USA). In vitro DNA-PK assays were performed essentially as described previously (Schild-Poulter et al., 2001 . Trypsin digestion and analysis of radiolabeled phosphorylated Oct-1 peptides were carried out with TPCK-treated trypsin (Worthington Biochemical Corporation, Freehold, NJ, USA) following a previously published procedure (Soubeyrand et al., 2004) and manual Edman degradation was performed as described (Giffin et al., 1997) .
